Dean Y. Li - 01 Oct 2025 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role: Director
Signature: /s/ Jonathan Golightly, attorney-in-fact
Issuer symbol: RXRX
Transactions as of: 01 Oct 2025
Net transactions value: $0
Form type: 4
Filing time: 03 Oct 2025, 16:27:37 UTC
Previous filing: 03 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Li Dean Y	Director	C/O RECURSION PHARMACEUTICALS, 41 S. RIO GRANDE STREET, SALT LAKE CITY	/s/ Jonathan Golightly, attorney-in-fact	03 Oct 2025	0001837016

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RXRX	Class A Common Stock	Award	$0	+1,961	+0.16%	$0.000000	1,238,528	01 Oct 2025	Direct	F1
holding	RXRX	Class A Common Stock						1,422,048	01 Oct 2025	By Dean Y. Li Revocable Trust
holding	RXRX	Class A Common Stock						136,981	01 Oct 2025	By Dean Y. Li GRAT
holding	RXRX	Class A Common Stock						421,000	01 Oct 2025	By Dean Y. Li 2021 Family Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.